Skip to main content
OCSL logo
OCSL
(NASDAQ)
Oaktree Specialty Lending Corporation
$11.39-- (--)
Loading... - Market loading

Oaktree Specialty Lending (OCSL) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Oaktree Specialty Lending Corporation
OCSLNASDAQFinancialsAsset Management

About Oaktree Specialty Lending

Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.

Company Information

CEOArmen Panossian
Founded2007
IPO DateJune 12, 2008
Employees17
CountryUnited States
Fiscal YearOctober - September

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone213 830 6300
Address
333 South Grand Avenue, 28th Floor Los Angeles, California 90071 United States

Corporate Identifiers

CIK0001414932
CUSIP67401P108
ISINUS67401P4054
EIN26-1219283

Leadership Team & Key Executives

Armen Panossian J.D.
Chief Executive Officer and Co-Chief Investment Officer
Mathew M. Pendo
President
Dr. Aman Kumar M.D.
Managing Director and Co-Portfolio Manager of Life Sciences Direct Lending
Christopher McKown
Chief Financial Officer and Treasurer
Brett McKeone
Chief Operating Officer
Raghav Khanna
Co-Chief Investment Officer
Dane Kleven
Senior Vice President and Head of Investor Relations
Mary Gallegly J.D.
MD,General Counsel and Secretary
Ashley Pak
Chief Compliance Officer
Sandeep Kumar Khorana
Managing Director of Origination